The Recall Desk
HighFDA (Devices)·Z-0048-2018·Announced 2017-11-01

GORE TAG Thoracic Endoprosthesis Recalled for Incomplete Deployment Risk

W.L. Gore & Associates is recalling 12,197 GORE TAG Thoracic Endoprosthesis units worldwide due to a risk of incomplete or partial deployment during endovascular procedures.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a risk of harm (incomplete deployment of a medical device) where specific injury reports are not detailed in the provided source text, fitting the 'High' severity criteria for risk-of-harm products.

Plain-English summary

W.L. Gore & Associates, Inc. is recalling 12,197 units of the GORE TAG Thoracic Endoprosthesis, Conformable. The device is intended for endovascular repair of all lesions of the descending thoracic aorta. The recall is being conducted worldwide.

The recall is due to the potential for incomplete and/or partial deployment of the device during the endovascular procedure. This issue could affect the intended function of the endoprosthesis.

Healthcare providers and patients who have received this device should contact W.L. Gore & Associates, Inc. for further instructions on how to proceed. The specific serial numbers affected are listed in the official recall documentation.

The recalled product

Product
GORE TAG, THORACIC ENDOPROSTHESIS, CONFORMABLE. The GORE TAG Thoracic Endoprosthesis is intended for endovascular repair of all lesions of the descending thoracic aorta.
Affected units
12,197

Distribution

Distribution scope not specified by the agency.